🧬Tidera Health
⚕️

Educational tool only. Does not confirm eligibility or provide medical advice. Always consult your physician before pursuing any trial.

DermatologyICD-10: L20

Find Recruiting Clinical Trials for Atopic Dermatitis (Eczema)

Search biologic, JAK inhibitor, and topical therapy trials for moderate-to-severe eczema matched to your treatment history.

🔍 Search Atopic Dermatitis (Eczema) Trials →

About Atopic Dermatitis (Eczema)

Atopic dermatitis (eczema) is a chronic inflammatory skin disease characterized by intensely itchy, inflamed skin. It affects up to 20% of children and 10% of adults worldwide. Modern treatments include dupilumab and tralokinumab (IL-4/IL-13 inhibitors), JAK inhibitors (upadacitinib, abrocitinib), and topical agents (crisaborole, tapinarof). Moderate-to-severe AD drives most clinical trial activity.

What Types of Atopic Dermatitis (Eczema) Clinical Trials Exist?

Atopic dermatitis trials test new biologics (IL-13, IL-31, IL-33 inhibitors), JAK inhibitors, topical therapies, and combination strategies. Most trials require moderate-to-severe disease (EASI ≥16 or IGA ≥3) and prior topical therapy failure.

Find Recruiting Atopic Dermatitis (Eczema) Trials Near You

Enter your profile and we'll search ClinicalTrials.gov in real time — matching trials to your age, location, and treatment history. Free, no account required.

Search Atopic Dermatitis (Eczema) Trials →

Data from ClinicalTrials.gov · Updated in real time · Educational use only

Frequently Asked Questions

What clinical trials are available for atopic dermatitis?▾
Recruiting eczema trials include new biologic targets (anti-IL-13, anti-IL-31, anti-OX40), oral JAK inhibitors, novel topical agents, and long-term safety studies. Most target moderate-to-severe disease.
Can I join an atopic dermatitis trial if I use dupilumab?▾
Many AD trials require a washout period from dupilumab or other biologics before enrollment. Some trials specifically seek patients who had inadequate response to dupilumab. Check trial eligibility carefully.
What severity scores are used in atopic dermatitis trials?▾
Common AD severity measures in trial eligibility include EASI (Eczema Area and Severity Index), IGA (Investigator Global Assessment), NRS pruritus scores, and SCORAD. Most moderate-to-severe trials require EASI ≥16 or IGA ≥3.

Related Conditions

PsoriasisChronic Spontaneous UrticariaPrurigo Nodularis

Data source: All clinical trial information is sourced from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Tidera Health is an independent educational platform and is not affiliated with ClinicalTrials.gov or the National Library of Medicine. Always verify trial details directly with the research coordinator or your physician.